Company / Free Cash Flow
Avidity Biosciences, Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$663.8M
FY2025
5-year range
-$663.8M / -$98.6M
FY2021-FY2025
Trend
-115.6%
vs FY2024
Sector context
#189 of 194
Health Care
What the data says
Among 194 Health Care companies, Avidity Biosciences, Inc. is in the bottom 3% for free cash flow. Free Cash Flow has fluctuated over the past 8 years, ranging from -$664M in FY2025 to $2M in FY2019.
Based on SEC 10-K filings.
-$664M in FY2025.
Declined from -$123M to -$664M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 194This company -$663.8M Sector average $470.6M
▼
-241.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 115.6% year-over-year.
- Ranks #189 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$663.8M | -115.6% |
| FY2024 | -$307.9M | -149.8% |
| FY2023 | -$123.3M | +11.4% |
| FY2022 | -$139.1M | -41.1% |
| FY2021 | -$98.6M | -157.9% |
| FY2020 | -$38.2M | -1794.4% |
| FY2019 | $2.3M | +123.2% |
| FY2018 | -$9.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026